Oncotelic Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 79.6M |
| FY2018 | 20.5M |
| FY2019 | 252.2M |
| FY2020 | 264.3M |
| FY2021 | 303.1M |
| FY2022 | 457.3M |
| FY2023 | 396.2M |
| FY2024 | 404.4M |
| FY2025 | 422.2M |
| FY2026 | 444.2M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 79.6M |
| FY2018 | 20.5M |
| FY2019 | 252.2M |
| FY2020 | 264.3M |
| FY2021 | 303.1M |
| FY2022 | 457.3M |
| FY2023 | 396.2M |
| FY2024 | 404.4M |
| FY2025 | 422.2M |
| FY2026 | 444.2M |